We are live on
!
Find out more
JG
Jain Global Portfolio holdings
AUM
$24.2B
1-Year Est. Return
34.82%
This Fund
S&P 500
This Quarter
Est. Return
+4.98%
1 Year Est. Return
+34.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.35B
AUM Growth
–
Cap. Flow
+$3.4B
Cap. Flow
% of AUM
101.56%
Top 10 Holdings %
Top 10 Hldgs %
35.48%
Holding
718
New
718
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$704M |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$73.7M |
| 3 |
FedEx
FDX
|
+$66M |
| 4 |
RTX Corp
RTX
|
+$60M |
| 5 |
Meta Platforms (Facebook)
META
|
+$56.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.54% |
| 2 | Industrials | 15.77% |
| 3 | Financials | 9.36% |
| 4 | Energy | 6.46% |
| 5 | Consumer Discretionary | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
ZipRecruiter
ZIP
$318M
| $77.7K | ﹤0.01% |
+10,732
| New | +$96K |
|
|
INFN
702
DELISTED
Infinera Corporation Common Stock
INFN
| $76.9K | ﹤0.01% |
+11,700
| New | +$78K |
|
|
CMRC
703
Commerce.com Inc Series 1
CMRC
$224M
| $73K | ﹤0.01% |
+11,924
| New | +$74.6K |
|
704
Fulcrum Therapeutics
FULC
$248M
| $72.4K | ﹤0.01% |
+15,409
| New | +$56.8K |
|
705
RLX Technology
RLX
$2.48B
| $69.6K | ﹤0.01% |
+32,200
| New | +$57.9K |
|
706
Alector
ALEC
$164M
| $69.5K | ﹤0.01% |
+36,775
| New | +$138K |
|
707
Aclaris Therapeutics
ACRS
$730M
| $60.7K | ﹤0.01% |
+24,460
| New | +$60.9K |
|
708
Santander
BSBR
$39.7B
| $60.2K | ﹤0.01% |
+15,405
| New | +$70.5K |
|
709
Grab
GRAB
$13.5B
| $59K | ﹤0.01% |
+12,502
| New | +$56.9K |
|
710
Coeur Mining
CDE
$15.6B
| $57.8K | ﹤0.01% |
+10,100
| New | +$65.4K |
|
711
Shoals Technologies Group
SHLS
$1.58B
| $57.7K | ﹤0.01% |
+10,441
| New | +$53K |
|
|
MTTR
712
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $53.6K | ﹤0.01% |
+11,300
| New | +$53.6K |
|
713
Perspective Therapeutics
CATX
$332M
| $45K | ﹤0.01% |
+14,100
| New | +$115K |
|
714
Prospect Capital
PSEC
$1.06B
| $44.8K | ﹤0.01% |
+10,391
| New | +$49.8K |
|
|
SGMO
715
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $39.9K | ﹤0.01% |
+39,100
| New | +$71.5K |
|
716
Puma Biotechnology
PBYI
$406M
| $36.2K | ﹤0.01% |
+11,871
| New | +$34.5K |
|
717
ChargePoint
CHPT
$133M
| $26.9K | ﹤0.01% |
+1,255
| New | +$31.1K |
|
718
Actinium Pharmaceuticals
ATNM
$27M
| $13.6K | ﹤0.01% |
+10,831
| New | +$16.8K |
|
Similar funds
SC
CS
Jain Global's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for Jain Global, which disclosed 718 positions worth $3.35B. Its ten largest holdings account for 35% of the portfolio.
Its largest position is iShares Core S&P 500 ETF: 1,190,000 shares worth $701M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, followed by Industrials and Financials.
- Jain Global's largest Q4 2024 buy was iShares Core S&P 500 ETF: 1,190,000 shares worth $701M.
- Jain Global's ten largest holdings make up 35% of its $3.35B portfolio in Q4 2024.
- Jain Global disclosed 718 positions in Q4 2024, its first 13F filing on record.
Based on Jain Global's 13F filing for Q4 2024, filed 14 Feb 2025.